Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme ...
Oct. 29, 2025 — FastWave Medical presented new first-in-human (FIH) and pre-clinical data for its Sola coronary laser ...
Oct. 27, 2025 — At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting in San Francisco, Royal ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...
Oct. 28, 2025 — People who underwent a minimally invasive procedure to have their heart’s aortic valve replaced had ...
Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...
Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...
Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Oct. 23, 2025— Emboline, Inc., a provider of full-body embolic protection devices for transcatheter procedures, thas ...
Oct. 26, 2025 – Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular ...
Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Oct. 27, 2025 — The American Heart Association (Association) has launched its latest professional certification program ...
Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...
Oct. 21, 2025 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...
October 31, 2025
